Il-17 Induced Notch1 Activation In Oligodendrocyte Progenitor Cells Enhances Proliferation And Inflammatory Gene Expression

Chenhui Wang,Cun-Jin Zhang,Bradley N. Martin,Katarzyna Bulek,Zizhen Kang,Junjie Zhao,Guanglin Bian,Julie A. Carman,Ji Gao,Ashok Dongre,Haibo Xue,Stephen D. Miller,Youcun Qian,Dolores Hambardzumyan,Tom Hamilton,Richard M. Ransohoff,Xiaoxia Li
DOI: https://doi.org/10.1038/ncomms15508
IF: 16.6
2017-01-01
Nature Communications
Abstract:NOTCH1 signalling contributes to defective remyelination by impairing differentiation of oligodendrocyte progenitor cells (OPCs). Here we report that IL-17 stimulation induces NOTCH1 activation in OPCs, contributing to Th17-mediated demyelinating disease. Mechanistically, IL-17R interacts with NOTCH1 via the extracellular domain, which facilitates the cleavage of NOTHC1 intracellular domain (NICD1). IL-17-induced NOTCH1 activation results in the interaction of IL-17R adaptor Act1 with NICD1, followed by the translocation of the Act1-NICD1 complex into the nucleus. Act1-NICD1 are recruited to the promoters of several NOTCH1 target genes (including STEAP4, a metalloreductase important for inflammation and cell proliferation) that are specifically induced in the spinal cord by Th17 cells. A decoy peptide disrupting the IL-17RA-NOTCH1 interaction inhibits IL-17-induced NOTCH1 activation and attenuates Th17-mediated experimental autoimmune encephalitis (EAE). Taken together, these findings demonstrate critical crosstalk between the IL-17 and NOTCH1 pathway, regulating Th17-induced inflammatory and proliferative genes to promote demyelinating disease.
What problem does this paper attempt to address?